Endometrial cancer currently represents the most frequent gynecologic malignancy in Western countries, and the seventh most common cancer in women. For advanced-stage disease, the recurrence risk is high, and the site of the relapse is heterogeneous with localized or spread peritoneal disease. There are few therapeutic strategies, and the quality of life is poor.
Intraperitoneal Chemotherapy: A Strategy for the Treatment of Refractory Ascites in Recurrent Endometrial Cancer Patients - Three Case Reports and Review of the Literature / Perniola, Giorgia; Santangelo, Giusi; Palaia, Innocenza; Musella, Angela; Tomao, Federica; Di Donato, Violante; Muzii, Ludovico; Benedetti Panici, Pierluigi. - In: ONCOLOGY. - ISSN 0030-2414. - 98:2(2019), pp. 98-101. [10.1159/000503393]
Intraperitoneal Chemotherapy: A Strategy for the Treatment of Refractory Ascites in Recurrent Endometrial Cancer Patients - Three Case Reports and Review of the Literature
Perniola, Giorgia;Santangelo, Giusi
;Palaia, Innocenza;Musella, Angela;Tomao, Federica;Di Donato, Violante;Muzii, Ludovico;Benedetti Panici, Pierluigi
2019
Abstract
Endometrial cancer currently represents the most frequent gynecologic malignancy in Western countries, and the seventh most common cancer in women. For advanced-stage disease, the recurrence risk is high, and the site of the relapse is heterogeneous with localized or spread peritoneal disease. There are few therapeutic strategies, and the quality of life is poor.| File | Dimensione | Formato | |
|---|---|---|---|
|
Perniola_Intraperitoneal_2019.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
63.06 kB
Formato
Adobe PDF
|
63.06 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
